Dyne Therapeutics, Inc. (DYN) has a market capitalization of $3.27B and trades at $19.81. The 52-week range is 6.36-25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.7, Earnings Per Share (EPS) of $-3.47.
The stock has a beta of 1.29, operates in the Healthcare sector.
